What Lipella Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kaufman Jonathan H | See remarks below. | May 14 | Open-market buy · P | +10,000 | $0.76 | +$7.59K | 898,849 |
| Kaufman Jonathan H | See remarks below. | Mar 19 | Open-market buy · P | +25,000 | $0.87 | +$21.8K | 888,849 |
| Kaufman Jonathan H | See remarks below. | Mar 18 | Open-market buy · P | +30,000 | $0.79 | +$23.6K | 863,849 |
| Chancellor Michael B | Chief Medical Officer | Mar 13 | Grant / award · A | +144,906 | $0.69 | +$100K | 877,637 |
| Kaufman Jonathan H | See remarks below. | Mar 13 | Grant / award · A | +144,906 | $0.69 | +$100K | 833,849 |
| Chancellor Michael B | Chief Medical Officer | Dec 22 | Other Transaction · J | +22,950 | $5.75 | +$132K | 732,730 |
Loading...
